Samuel T. Savitz

Mar 30, 2023 | frontiersin.org | Gen-Min Lin |Wojciech Zareba |Samuel T. Savitz

Introduction Implantable cardioverter-defibrillator (ICD) placement is an established interventional therapy for primary prevention of sudden cardiac death (SCD) in patients with heart failure with reduced ejection fraction (HFrEF) (1). Heart Failure (HF) is more common among older (≥65 years) populations and is projected to affect >8 million adults in the United States by 2030 as the population ages (2). Both non-cardiovascular (CV) and CV hospitalizations are common among HF patients (2).